NP
BSX icon

Nilsine Partners’s Boston Scientific BSX Stock Holding History

Nilsine Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,184
Closed -$4.21M – 429
2025
Q4 		$4.21M Buy
44,184
+3,509
+9% +$344K 0.37% 59
2025
Q3 		$3.97M Buy
40,675
+4,064
+11% +$421K 0.36% 61
2025
Q2 		$3.93M Buy
36,611
+31,341
+595% +$3.17M 0.4% 56
2025
Q1 		$532K Sell
5,270
-15
-0.3% -$1.51K 0.06% 234
2024
Q4 		$472K Buy
5,285
+437
+9% +$38.5K 0.05% 261
2024
Q3 		$406K Sell
4,848
-514
-10% -$40.5K 0.05% 246
2024
Q2 		$413K Sell
5,362
-141
-3% -$10.3K 0.06% 241
2024
Q1 		$377K Sell
5,503
-85
-2% -$5.46K 0.05% 247
2023
Q4 		$323K Sell
5,588
-4,003
-42% -$214K 0.05% 257
2023
Q3 		$506K Buy
9,591
+47
+0.5% +$2.46K 0.08% 225
2023
Q2 		$516K Sell
9,544
-670
-7% -$35K 0.08% 226
2023
Q1 		$511K Buy
+10,214
New +$481K 0.08% 230

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nilsine Partners's BSX Position: Q1 2026 in Review

Nilsine Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 44,184 shares — an estimated $4.21M sold.

Nilsine Partners first reported a position in BSX in Q1 2023 and held it in 12 quarters. The position peaked at $4.21M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Nilsine Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Nilsine Partners sold 44,184 Boston Scientific shares in Q1 2026, an estimated $4.21M.
  • Nilsine Partners first reported a position in Boston Scientific in Q1 2023 and held it in 12 quarters.
  • Nilsine Partners's Boston Scientific position peaked at $4.21M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Nilsine Partners's 13F filing for Q1 2026, filed 29 Apr 2026.